Home > ABOUT SIMR > Milestones
Milestones
  • Company Profile
  • Management Team
  • Vision & Mission
  • Milestones
  • Investors
  • 2019
    July-SIMR initiated the first-in-human study of candidate drug SR419 for peripheral neuropathic pain
    2018
    November - Received over 100 million RMB for A round of financing
    May - The SPF animal facilities passed the on-site audit
    2017
    May - SIMR received financial support from the Smart Manufacturing Industry in Lingang
    2016
    November - Received over ten millions RMB for Pre-A round of financing
    SIMR was granted as one of the "50 Best Startups with Highest Investment Potential in Shanghai"
    2015
    2014
    March 6 - Shanghai SIMR Biotechnology Co., Ltd. was established in Shanghai.